Barclays’s eXoZymes EXOZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47 Sell
8
-67
-89% -$415 ﹤0.01% 5085
2026
Q2
$632 Buy
+75
New +$707 ﹤0.01% 4975

Other funds holding EXOZ

Barclays's EXOZ Position: Q3 2026 in Review

Barclays reduced its eXoZymes (EXOZ) stake by 89% in Q3 2026, selling an estimated $415 and leaving 8 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #5085.

Barclays first reported a position in EXOZ in Q2 2026 and has held it in 2 quarters since. The position peaked at $632 in Q2 2026. 9 funds tracked by Wall St. Rank hold EXOZ as of Q3 2026.

  • Barclays held 8 shares of eXoZymes worth $47 as of Q3 2026.
  • Barclays sold 67 eXoZymes shares in Q3 2026, an estimated $415.
  • eXoZymes made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5085 holding.
  • Barclays first reported a position in eXoZymes in Q2 2026 and has held it in 2 quarters since.
  • Barclays's eXoZymes position peaked at $632 in Q2 2026.
  • 9 funds tracked by Wall St. Rank held eXoZymes as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.